Souhaitez-vous accéder aux communiqués récents ?

Agenda topics have been revealed for the 2025 Identity & Payments Summit!

SATO Oyj, Pörssitiedote 11.12.2024 klo 15.30 SATO Oyj:n taloudellinen tiedottaminen vuonna 2025 Vuonna 2025 SATO julkaisee taloudellisia raportteja seuraavan aikataulun mukaisesti: 7.2.2025       ...

SATO Corporation, Stock exchange release, 11 December 2024 at 3:30 pm SATO Corporation’s financial communications 2025 In 2025, SATO will publish financial reports in accordance with the following...

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®,...

BETHESDA, Md., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...

1 MG Dose (Z)-Endoxifen Shows Potential as a Well-Tolerated, Preventative Therapy for Premenopausal Women at Risk of Developing Breast Cancer Data to be Presented in a Poster Spotlight Session During...

ALISO VIEJO, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ValueRock Realty, a national real estate investment and operations company, announced the grand opening of The Commons, a newly repurposed...

SUNNYVALE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the infrastructure software company for smart-world systems, will exhibit at CES 2025, held January 7 – 10, in Las...

DELAWARE, Ohio, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, is hosting an Investor Day in New York City today,...

MORRISTOWN, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health...